Evidence map›Paper›PMID 28810819›Full record

ArticleStem cells and development2017

Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34

Yan-Yu Wang, Wen-Lian Chen, Xiang-Qin Weng, Yan Sheng, Jing Wu, Jie Hao, Zhan-Yun Liu, Yong-Mei Zhu, Bing Chen, Shu-Min Xiong and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cells and development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Yan-Yu Wang1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Wen-Lian Chen4 University of Hawaii Cancer Center , Honolulu, Hawaii.
Xiang-Qin Weng1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Yan Sheng1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Jing Wu1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Jie Hao2 Department of Hematology, Bei Zhan Hospital , Shanghai, China .
Zhan-Yun Liu2 Department of Hematology, Bei Zhan Hospital , Shanghai, China .
Yong-Mei Zhu1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Bing Chen1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Shu-Min Xiong1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Yu Chen1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Qiu-Sheng Chen1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Hui-Ping Sun1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Jun-Min Li1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Jin Wang1 State Key Laboratory of Medical Genomics, Department of Hematology, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China .
Hubei Zhongshan Hospital · CNUniversity of Hawaiʻi at Mānoa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent reports state that C-type lectin-like molecule-1 (CLL-1) in acute myeloid leukemia (AML) is expressed primarily on myeloid cells, but there is still no investigation about its prognostic significance on leukemic blast compartment. Hence, this study aimed to evaluate the prognostic value of CLL-1 in 123 patients with de novo CD34

Indexed as

AdolescentAdultAgedAntigens, CD34Disease-Free SurvivalFemaleFlow CytometryHumansKaplan-Meier EstimateLectins, C-TypeLeukemia, Myeloid, AcuteMaleMiddle AgedMultivariate AnalysisPrognosisRemission InductionAntigens, CD34Lectins, C-Typeacute myeloid leukemiaa novel adverse predictorlow CLL-1 expression

Identifiers

PMID28810819
PMCPMC5651960
OpenAlexW2746119088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.